Jonathan Haug

Mr. Jonathan R.
Haug is a President & Director at Atai Beckley, Inc., a President & Director at Ventyx Biosciences, Inc., a President & Director at Adverum Biotechnologies, Inc., a President at Verve Therapeutics, Inc., a Chief Executive Officer at ARMO Biosciences, Inc., a Chief Executive Officer at DICE Therapeutics, Inc., a President & Director at Morphic Holding, Inc. and a President & Director at Scorpion Therapeutics, Inc. He is on the Board of Directors at Atai Beckley, Inc., Ventyx Biosciences, Inc., Adverum Biotechnologies, Inc., Morphic Holding, Inc. and Scorpion Therapeutics, Inc. Mr. Haug was previously employed as a Chief Executive Officer by Prevail Therapeutics, Inc.